Introduction
Unlike the care in the United States, the mortality from cardiovascular disease is not apparently falling in Britain, so clearly peripheral vascular disease too will remain a problem. The benefits and risks of surgery are now clearly defined,' but there will always be patients unsuitable for surgery because of cardiac disease or stroke, and those with extensive vascular disease not amenable to surgical correction. These patients create a therapeutic problem for general practitioner and vascular surgeon alike.
Natural history of peripheral vascular disease
The natural course of peripheral vascular disease is not usually an unremitting path leading to amputation but is more often characterised either by stable intermittent claudication or improvement of symptoms. Nevertheless, complications may be precipitated by an acute embolus or thrombosis of a segment of artery with a patient having acquired an increased walking distance to the onset of pain between the time of general practitioner referral and hospital consultation. This will be due to both clot or embolus resolution and development of collateral blood supply. Clearly then the therapeutic benefit of any regimen must be judged critically against a control group before any pronouncement may be made as to its efficacy. If one accepts that Poseuille's formula (flow= (P x r4)/(V x L), where P =pressure, r=radius of vessel, V =viscosity, and L= length of vessel; designed for the flow of Newtonian fluids, which blood is not) may have some bearing on limb blood flow, to be effective a drug must possess one of the actions listed in table I. Double-blind trials are imperative, as in most studies the placebo group will increase their distance to claudication, and techniques such as the walking test23 allow for standard reproducible methods of assessing the state of the disease.
"Vasodilators" either deplete noradrenaline from nerve endings, block the effects of noradrenaline (oa-adrenergic blockers), or exert a direct effect on the blood vessel wall.24 Many will increase blood flow at rest in patients with occluded ischaemic muscle. Beta-adrenergic blockers, however, do reduce peripheral muscle perfusion31 and have been reported to exacerbate and even produce claudication.32 There are even sporadic reports of peripheral gangrene due to r-blockade.33 Symptoms of peripheral vascular disease should be closely monitored in patients taking n-blockers.
Alterations in blood rheology
Much evidence supports the concept of increased blood viscosity in patients with peripheral vascular disease,34 and this is usually due to increased serum fibrinogen.35 Defibrination may be achieved with ancrod36 or clofibrate,3 which may give clinical improvement. Even plasma exchange causing a rapid fall Percutaneous transluminal dilatation of arteries fills most surgeons with horror, but favourable reports are emerging which suggest that peripheral arteries5 (and indeed coronary arteries54) may be effectively dilated via a transtemoral route under local anaesthetic. Better results without complications must be achieved than those reported by workers using the original Dotter technique55 before this could-become an accepted procedure.
Spinal cord stimulation by electrodes implanted into the epidural space may relieve limb pain and improve muscle tone in several diseases.56 Some reports of its possible role in the management of symptoms from an ischaemic limb exist,57 58 and these are now being evaluated in a proper clinical and scientific background.5 9 Finally, some believe help may soon be to hand with the discovery of prostacyclin and its analogues.60 These agents appear to influence intravascular thrombosis through inhibition of platelet aggregation by stimulation of adenylate-cyclase leading to an increased concentration of cyclic 3'5' adenosine monophosphate in the platelets. They might offer short-term help in the acutely ischaemic limb65 but, of more importance, they could improve our ability to prevent vascular disease through a better understanding of blood vessel pathophysiology.
I wish to acknowledge the advice of Charles George, professor of clinical pharmacology, in the preparation of this manuscript and the Department of Health and Social Security for allowing me to publish data supplied by them and prepared by Mr D E Hands, principle pharmacist, Southampton General Hospital. James Boswell's diaries, for example, are filled with the accounts of the contests between himself and Lord Auchinleck, which were conducted on all four fronts. He hated the law (his father was a judge) and wished to join the Army. He was sexually promiscuous. For a time he became a Roman Catholic; Auchinleck was an orthodox Presbyterian who extolled Cromwell to Dr Johnson as the man "who taught kings that they had a lith in their necks." James was a spendthrift who begged continually for additional funds. Their conflicts were exacerbated by profound differences in character and temperament. James was volatile, friendly, idle, and indiscreet. His father was rigid, stem, industrious, and close. "James, Jamie," protested the outraged Auchinleck, " 
